OpenURL Connection Search

Select item for more details and to access through your institution.

The influence of continuous venovenous renal replacement therapy on the plasma disappearance rate of indocyanine green.
Published in:
2013
By:
- Ameloot, K.;
- Meersseman, P.;
- Wilmer, A.;
- Hermans, G.;
- Gerits, A.;
- Spriet, I.;
- Wauters, J.
Publication type:
Letter
Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.
Published in:
2020
By:
- Vanassche, T.;
- Engelen, M. M.;
- Van Thillo, Q.;
- Wauters, J.;
- Gunst, J.;
- Wouters, C.;
- Vandenbriele, C.;
- Rex, S.;
- Liesenborghs, L.;
- Wilmer, A.;
- Meersseman, P.;
- Van den Berghe, G.;
- Dauwe, D.;
- Verbeke, G.;
- Thomeer, M.;
- Fivez, T.;
- Mesotten, D.;
- Ruttens, D.;
- Heytens, L.;
- Dapper, I.
Publication type:
corrected article
A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.
Published in:
2020
By:
- Vanassche, T.;
- Engelen, M. M.;
- Van Thillo, Q.;
- Wauters, J.;
- Gunst, J.;
- Wouters, C.;
- Vandenbriele, C.;
- Rex, S.;
- Liesenborghs, L.;
- Wilmer, A.;
- Meersseman, P.;
- Van den Berghe, G.;
- Dauwe, D.;
- Verbeke, G.;
- Thomeer, M.;
- Fivez, T.;
- Mesotten, D.;
- Ruttens, D.;
- Heytens, L.;
- Dapper, I.
Publication type:
journal article
Heart rate time series characteristics for early detection of infections in critically ill patients.
Published in:
2017
By:
- Tambuyzer, T.;
- Guiza, F.;
- Boonen, E.;
- Meersseman, P.;
- Vervenne, H.;
- Hansen, T.;
- Bjerre, M.;
- Berghe, G.;
- Berckmans, D.;
- Aerts, J.;
- Meyfroidt, G.;
- Hansen, T K;
- Van den Berghe, G;
- Aerts, J M
Publication type:
journal article

Found: 4

The influence of continuous venovenous renal replacement therapy on the plasma disappearance rate of indocyanine green.

Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.

A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.

Heart rate time series characteristics for early detection of infections in critically ill patients.